Richard Poulton - Feb 15, 2022 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)

Role
President & CFO
Signature
Holly O'Berry by power of attorney for Richard Poulton
Stock symbol
MDRX
Transactions as of
Feb 15, 2022
Transactions value $
-$415,637
Form type
4
Date filed
2/16/2022, 06:15 PM
Previous filing
Feb 11, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDRX Common Stock Sale -$208K -10K -1.85% $20.83 532K Feb 15, 2022 Direct F1, F2
transaction MDRX Common Stock Sale -$207K -10K -1.88% $20.74 522K Feb 16, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 These transactions were executed in multiple trades at prices ranging from $20.676 to $20.95. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These transactions were executed in multiple trades at prices ranging from $20.56 to $20.855. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.